Scott Mackay

Mr. Scott Mackay

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 September 2015 in Sensors
Verified
Journal Article
Open access
PDF file
SMScott Mackay
Scott Mackay
PHPeter Hermansen
Peter Hermansen
David Scott WishartDavid Scott Wishart
David Scott Wishart
JCJie Chen
Jie Chen
In this paper, we describe a point-of-care biosensor design. The uniqueness of our design is in its capability for detecting a wide variety of target biomolecules and the simplicity of nanoparticle enhanced electrical detection. The electrical properties of interdigitated electrodes (IDEs) and the mechanism for gold nanoparticle-enhanced impedance-based biosensor systems based on these electrodes are simulated using COMSOL Multiphysics software. Understanding these properties and how they can be affected is vital in designing effective biosensor devices. Simulations were used to show electrical screening develop over time for IDEs in a salt solution, as well as the electric field between individual digits of electrodes. Using these simulations, it was observed that gold nanoparticles bound closely to IDEs can lower the electric field magnitude between the digits of the electrode. The simulations are also shown to be a useful design tool in optimizing sensor function. Various different conditions, such as electrode dimensions and background ion concentrations, are shown to have a significant impact on the simulations.

18 September 2017 in Sensors
Verified
Journal Article
Open access
PDF file
SMScott Mackay
Scott Mackay
GAGaser N. Abdelrasoul
Gaser N. Abdelrasoul
MTMarcus Tamura
Marcus Tamura
DLDonghai Lin
Donghai Lin
ZYzhimin yan
zhimin yan
JCJie Chen
Jie Chen
With the increased practice of preventative healthcare to help reduce costs worldwide, sensor technology improvement is vital to patient care. Point-of-care (POC) diagnostics can reduce time and lower labor in testing, and can effectively avoid transporting costs because of portable designs. Label-free detection allows for greater versatility in the detection of biological molecules. Here, we describe the use of an impedance-based POC biosensor that can detect changes in the surface modification of a micro-fabricated chip using impedance spectroscopy. Gold nanoparticles (GNPs) have been employed to evaluate the sensing ability of our new chip using impedance measurements. Furthermore, we used impedance measurements to monitor surface functionalization progress on the sensor’s interdigitated electrodes (IDEs). Electrodes made from aluminum and gold were employed and the results were analyzed to compare the impact of electrode material. GNPs coated with mercaptoundecanoic acid were also used as a model of biomolecules to greatly enhance chemical affinity to the silicon substrate. The portable sensor can be used as an alternative technology to ELISA (enzyme-linked immunosorbent assays) and polymerase chain reaction (PCR)-based techniques. This system has advantages over PCR and ELISA both in the amount of time required for testing and the ease of use of our sensor. With other techniques, larger, expensive equipment must be utilized in a lab environment, and procedures have to be carried out by trained professionals. The simplicity of our sensor system can lead to an automated and portable sensing system.

3 May 2024 in Nanomaterials
Verified
Journal Article
Open access
PDF file
SJSajjad Janfaza
Sajjad Janfaza
Nandhinee Radha ShanmugamNandhinee Radha Shanmugam
Nandhinee Radha Shanmugam
PJPawan Jolly
Pawan Jolly
Prashanthi KovurPrashanthi Kovur
Prashanthi Kovur
USUpasana Singh
Upasana Singh
DIDonald E Ingber
Donald E Ingber
Continuous glucose monitoring is valuable for people with diabetes but faces limitations due to enzyme–electrode interactions and biofouling from biological samples that reduce sensor sensitivity and the monitoring performance. We created an enzyme-based electrochemical system with a unique nanocomposite coating that incorporates the redox molecule, aminoferrocene (NH2-Fc). This coating enhances stability via electroactivity and reduces nonspecific binding, as demonstrated through cyclic voltammetry. Our approach enables real-time glucose detection via chronoamperometry with a calculated linear range of 0.5 to 20 mM and a 1 mM detection limit. Validated with plasma and saliva, this platform shows promise for robust metabolite detection in clinical and research contexts. This versatile platform can be applied to accurately monitor a wide range of metabolites in various biological matrices, improving patient outcomes.

1 August 2025 in JCO Global Oncology
Verified
Journal Article
Closed access
OAOlusegun I. Alatise
Olusegun I. Alatise
David Scott WishartDavid Scott Wishart
David Scott Wishart
SMScott Mackay
Scott Mackay
OOOlalekan Olasehinde
Olalekan Olasehinde
FWFunmilola Wuraola
Funmilola Wuraola
TKT. Peter Kingham
T. Peter Kingham
PURPOSE: To test the feasibility of a point-of-care (POC) real-time urine metabolomics test, evaluate its validity in diagnosing colorectal cancer (CRC) among at-risk patients, and assess the willingness of patients in Southwestern Nigeria to use and pay for the test. METHODS: This was a pilot-controlled trial carried out among 72 patients (34 cases and 38 controls) in southwestern Nigeria. The cases were those with histopathological diagnosis of CRC while controls were at-risk adults. The POC biosensor used a disposable chip and can be connected to a smart device using Bluetooth, and reported if the patient's urine contained metabolites consistent with CRC. We assessed validity of the test using sensitivity, specificity, positive predictive value (PPV) and negative predictive values (NPV), and prespecified a specificity of 50% with a goal of ≥80% sensitivity to estimate the potential of the test to half the referrals to colonoscopy. Additionally, we assessed perception toward the test and willingness to uptake the urine test using structured questionnaires. RESULTS: The overall sensitivity, specificity, PPV, and NPV for all respondents were 91.18%, 81.58%, 81.58%, and 91.18% respectively, with an area under the receiver operating characteristic curve of 0.86. With specificity fixed at 50%, the overall sensitivity for all respondents was 94.5%, and all stratifications had sensitivity >90%. Overall, 70 (98.6%) were satisfied with the urine-based CRC screening, and respondents were willing to pay a mean amount of 8,008.20 Naira (about $5.2 US dollars) for the test. CONCLUSION: Our urine metabolite early diagnosis POC test met our predetermined criteria for success and had high acceptance rates among Nigerian patients, supporting a future multi-institutional implementation trial assessing our ability to scale up utilization.

2 September 2026 in Biosensors
Verified
Journal Article
Open access
PDF file
Prashanthi KovurPrashanthi Kovur
Prashanthi Kovur
SMScott Mackay
Scott Mackay
SBSong Tian Bai
Song Tian Bai
JCJames Daniel Joseph Cook
James Daniel Joseph Cook
CTClaudia Torres-Calzada
Claudia Torres-Calzada
David Scott WishartDavid Scott Wishart
David Scott Wishart
Early detection of colorectal cancer (CRC) is challenging in low-resource settings because access to colonoscopy and centralized laboratory testing is limited. Urine-based metabolite biomarkers offer a non-invasive alternative for CRC triage, but translating a laboratory assay into a point-of-care (PoC) system requires standardized fluid handling, operator-independent timing, field-compatible reagents, and quantitative calibration. Here, we present a low-cost, semi-automated PoC platform integrating a validated, sequential, three-metabolite CRC-biomarker assay with robotic fluid handling, a motorized chromatographic module, an optical reader, Bluetooth electronics, and tablet-guided control. The platform measures urinary diacetylspermine and hippuric acid, with creatinine serving as a normalization reference, and reports absolute quantitative concentrations. Automated dilution, tube positioning, timed incubation, controlled column elution, and software-guided transfer reduce operator-dependent variation. Using pooled urine samples spiked at clinically relevant concentrations, the creatinine assay showed a strong quadratic response (0–50 mM, R2 = 0.998), as did the diacetylspermine assay (0–4 μM, R2 = 0.979), while the hippuric acid assay showed a linear response of R2 = 0.989. The RGB sensor tracked the concentration-dependent trend observed with a laboratory microplate reader (R2 = 0.968–0.999). Reagents reformulated as lyophilized or pre-weighed, vacuum-sealed kits withstood accelerated heat and humidity (45 °C/70% RH) testing and international shipping to the pilot site very well. At approximately USD 490 for the complete instrument (including tablet) and roughly USD 7.65 in consumables per screening test, the platform offers a practical, quantitative, and portable route for decentralized CRC screening.

28 October 2026 in Engineering Proceedings
Verified
Conference Paper
Open access
PDF file
Prashanthi KovurPrashanthi Kovur
Prashanthi Kovur
SMScott Mackay
Scott Mackay
ANAmeen Naqvi
Ameen Naqvi
JCJames Daniel Joseph Cook
James Daniel Joseph Cook
CTClaudia Torres-Calzada
Claudia Torres-Calzada
David Scott WishartDavid Scott Wishart
David Scott Wishart
Early detection of sheep pregnancy and litter size (PLS) is crucial for the efficient management of the flock. However, standard ultrasonography for these purposes is not cost-effective for flock testing and requires trained and experienced operators. We have developed a simple handheld, real-time RGB color-sensor system that can measure six PLS candidate biomarkers, namely L-carnitine, glucose, lactate, creatinine, urea, and pyruvate using six in-house colorimetric assays, and a companion tablet application to report sheep PLS results. A benchtop microplate reader was used to obtain the measurements of the six assays using spiked, pooled sheep serum to produce a set of assay-specific weighted “color numbers” which were then used to calibrate the portable sensor system. To facilitate pregnancy testing in sheep during the coldest months of Canadian winter, we have also developed a custom-made temperature-controlled heating chamber so that the colorimetric assays can be incubated at approximately 21 °C. Here, we report on outdoor, on-device calibration of two chemically distinct assays spanning the concentration ranges represented in the panel. Creatinine, measured using the non-enzymatic alkaline 3,5-dinitrobenzoic acid reaction, increased monotonically over a concentration range of 0–200 µM (linear fit, R2 = 0.9469). Urea, measured using the enzyme-coupled Berthelot reaction, increased rapidly up to about 10 mM before saturating (quadratic fit, R2 = 0.9864). Both assays produced repeatable and concentration-dependent color change under the variable outdoor winter conditions experienced on-farm and therefore, hold great promise for the on-farm colorimetric measurement of metabolites of interest for pregnancy and litter size in sheep.